VIR Biotechnology (VIR) Stock
VIR Biotechnology (VIR) closed at $9.25 on Nov 17, 2026; its Tenet Score is 54 of 100 against 340 Healthcare peers.
24 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $9.25
- Nov 17, 2026
- Market cap
- $1.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 5.32 – 14.38
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 54/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Vir Biotechnology Inc scores 54/100. Mixed. Strongest on value and financial health, growth is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under t…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Recursion Pharmaceuticals IncRXRX | 53 | $1.8B |
| Agios Pharmaceuticals IncAGIO | 64 | $1.8B |
| Stoke Therapeutics IncSTOK | 50 | $1.7B |
| Certara IncCERT | 48 | $1.7B |
| Sarepta Therapeutics IncSRPT | 48 | $1.6B |
| ANI Pharmaceuticals IncANIP | 69 | $1.6B |
| Nurix Therapeutics IncNRIX | 84 | $1.6B |
| uniQure N.V.QURE | 37 | $1.5B |
| SELLAS Life Sciences Group IncSLS | 42 | $1.5B |
| Immunocore Holdings plcIMCR | 53 | $1.5B |
Common questions
What sector and industry is VIR Biotechnology in?
VIR Biotechnology is in the Healthcare sector and the Drugs industry.
What is VIR Biotechnology's Tenet Score?
VIR Biotechnology's Tenet Score is 54 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




